Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699472014 | Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3699473016 | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46812101000001116 | Co-phenotrope 2.5mg/0.025mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing atropine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing difenoxin hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing atropine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Atropine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Difenoxin hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing atropine sulfate and diphenoxylate hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Atropine sulfate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Diphenoxylate hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing atropine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Atropine sulfate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Atropine sulfate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 0.025 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Diphenoxylate hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Diphenoxylate hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Diphenoxylate hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Atropine sulfate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Atropine sulfate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Diphenoxylate hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing atropine and diphenoxylate in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Product containing only atropine and diphenoxylate in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 5 (CD Inv) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Atropine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has active ingredient | Diphenoxylate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has specific active ingredient | Atropine sulfate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has specific active ingredient | Diphenoxylate hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Is a | Co-phenotrope | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lomotil 2.5mg/25microgram tablets (Goldshield Healthcare Ltd) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Dymotil 2.5mg/25microgram tablets (Goldshield Healthcare Ltd) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets 100 tablet | Is pack of | False | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet | Is pack of | False | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets (Goldshield Pharmaceuticals Ltd) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lomotil 2.5mg/25microgram tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets (UniChem Ltd) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet | Has VMP | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets 100 tablet | Has VMP | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lomotil 2.5mg/25microgram tablets (Imported (Ireland)) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lofenoxal 2.5mg/25microgram tablets (Imported (Australia)) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets (Part VIIID Drug Tariff Special Order) | Is a | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-phenotrope 2.5mg/0.025mg tablets 1 tablet | Has VMP | True | Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets